479 related articles for article (PubMed ID: 34262212)
1. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome.
Han S; Van Treuren W; Fischer CR; Merrill BD; DeFelice BC; Sanchez JM; Higginbottom SK; Guthrie L; Fall LA; Dodd D; Fischbach MA; Sonnenburg JL
Nature; 2021 Jul; 595(7867):415-420. PubMed ID: 34262212
[TBL] [Abstract][Full Text] [Related]
2. Metabolome analysis for investigating host-gut microbiota interactions.
Chen MX; Wang SY; Kuo CH; Tsai IL
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
[TBL] [Abstract][Full Text] [Related]
3. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
[TBL] [Abstract][Full Text] [Related]
4. Strain-level dissection of the contribution of the gut microbiome to human metabolic disease.
Zhang C; Zhao L
Genome Med; 2016 Apr; 8(1):41. PubMed ID: 27098841
[TBL] [Abstract][Full Text] [Related]
5. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet.
Walker A; Pfitzner B; Neschen S; Kahle M; Harir M; Lucio M; Moritz F; Tziotis D; Witting M; Rothballer M; Engel M; Schmid M; Endesfelder D; Klingenspor M; Rattei T; Castell WZ; de Angelis MH; Hartmann A; Schmitt-Kopplin P
ISME J; 2014 Dec; 8(12):2380-96. PubMed ID: 24906017
[TBL] [Abstract][Full Text] [Related]
6. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
7. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice.
Marcobal A; Kashyap PC; Nelson TA; Aronov PA; Donia MS; Spormann A; Fischbach MA; Sonnenburg JL
ISME J; 2013 Oct; 7(10):1933-43. PubMed ID: 23739052
[TBL] [Abstract][Full Text] [Related]
8. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.
Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK
mBio; 2017 Oct; 8(5):. PubMed ID: 29042495
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
Xie G; Zhang S; Zheng X; Jia W
Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
[TBL] [Abstract][Full Text] [Related]
10. Metaproteomic and Metabolomic Approaches for Characterizing the Gut Microbiome.
Peters DL; Wang W; Zhang X; Ning Z; Mayne J; Figeys D
Proteomics; 2019 Aug; 19(16):e1800363. PubMed ID: 31321880
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota influenced the xenograft MC38 tumor growth potentially through interfering host lipid and amino acid metabolisms, basing on the integrated analysis of microbiome and metabolomics.
Chen MH; Zhou J; Wu CY; Zhang W; Long F; Zhou SS; Xu JD; Wu J; Zou YT; Li SL; Shen H
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123136. PubMed ID: 35151210
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Modeling To Monitor Host Responsiveness to Gut Microbiota Manipulation in the BTBR(T+tf/j) Mouse.
Klein MS; Newell C; Bomhof MR; Reimer RA; Hittel DS; Rho JM; Vogel HJ; Shearer J
J Proteome Res; 2016 Apr; 15(4):1143-50. PubMed ID: 26928523
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
Luan H; Wang X; Cai Z
Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
[TBL] [Abstract][Full Text] [Related]
14. Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition.
Zarei I; Koistinen VM; Kokla M; Klåvus A; Babu AF; Lehtonen M; Auriola S; Hanhineva K
Sci Rep; 2022 Sep; 12(1):15018. PubMed ID: 36056162
[TBL] [Abstract][Full Text] [Related]
15. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.
Li RJ; Jie ZY; Feng Q; Fang RL; Li F; Gao Y; Xia HH; Zhong HZ; Tong B; Madsen L; Zhang JH; Liu CL; Xu ZG; Wang J; Yang HM; Xu X; Hou Y; Brix S; Kristiansen K; Yu XL; Jia HJ; He KL
Front Cell Infect Microbiol; 2021; 11():708088. PubMed ID: 34692558
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial metabolites as multi-kingdom intermediates.
Krautkramer KA; Fan J; Bäckhed F
Nat Rev Microbiol; 2021 Feb; 19(2):77-94. PubMed ID: 32968241
[TBL] [Abstract][Full Text] [Related]
17. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites, and Metabolic Pathways.
Gao B; Chi L; Mahbub R; Bian X; Tu P; Ru H; Lu K
Chem Res Toxicol; 2017 Apr; 30(4):996-1005. PubMed ID: 28234468
[TBL] [Abstract][Full Text] [Related]
18. Spatial metabolomics of in situ host-microbe interactions at the micrometre scale.
Geier B; Sogin EM; Michellod D; Janda M; Kompauer M; Spengler B; Dubilier N; Liebeke M
Nat Microbiol; 2020 Mar; 5(3):498-510. PubMed ID: 32015496
[TBL] [Abstract][Full Text] [Related]
19. Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.
Zhao L; Wang C; Peng S; Zhu X; Zhang Z; Zhao Y; Zhang J; Zhao G; Zhang T; Heng X; Zhang L
J Transl Med; 2022 Oct; 20(1):459. PubMed ID: 36209079
[TBL] [Abstract][Full Text] [Related]
20. Investigating gut microbiota-blood and urine metabolite correlations in early sepsis-induced acute kidney injury: insights from targeted KEGG analyses.
Xu Y; Xu J; Zhu Y; Mao H; Li J; Kong X; Zhu X; Zhang J
Front Cell Infect Microbiol; 2024; 14():1375874. PubMed ID: 38887493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
